MedTrace Logo

Prevalence of Primary Aldosteronism in Young Adults With Acute Stroke

NCT04203420 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 116

Last updated 2019-12-18

No results posted yet for this study

Summary

The guideline requires clinical works to screen for primary aldosteronism(PA) in young adults with family history of stroke at early onset. But the prevalence of PA in young adults with stroke onset before 45 years old had never been investigated. The study aimed to discover the prevalence as well as the clinical characteristics between patients with PA and those without PA during stroke attack. In order to fulfill this objective, investigators intended to conduct a cross-sectional study by taking screening and confirmatory tests among young adults who once admitted due to early onset of acute stroke.

Conditions

  • Primary Aldosteronism

Interventions

OTHER

screening and confirmatory tests

screening test is a blood test of the ratio of plasma aldosterone concentration(PAC) and direct renin concentration(DRC), confirmatory test is Captopril Challenge test

Sponsors & Collaborators

  • Chongqing Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2019-11-01
Completion
2019-12-13

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04203420 on ClinicalTrials.gov